 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for NR2F2 |
 Gene summary |
| Basic gene information | Gene symbol | NR2F2 |
| Gene name | nuclear receptor subfamily 2, group F, member 2 | |
| Synonyms | ARP1|CHTD4|COUPTFB|COUPTFII|NF-E3|NR2F1|SVP40|TFCOUP2 | |
| Cytomap | UCSC genome browser: 15q26 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001145155.1, NM_001145156.1,NM_001145157.1,NM_021005.3, | |
| Description | ADP-ribosylation factor related protein 1COUP transcription factor 2COUP transcription factor IIapolipoprotein A-I regulatory protein 1apolipoprotein AI regulatory protein 1chicken ovalbumin upstream promoter transcription factor 2chicken ovalbumin | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 107773 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000185551 | ||
| HPRD : 00139 | ||
| Vega : OTTHUMG00000149848 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_NR2F2 | |
| BioGPS: 7026 | ||
| Pathway | NCI Pathway Interaction Database: NR2F2 | |
| KEGG: NR2F2 | ||
| REACTOME: NR2F2 | ||
| Pathway Commons: NR2F2 | ||
| Context | iHOP: NR2F2 | |
| ligand binding site mutation search in PubMed: NR2F2 | ||
| UCL Cancer Institute: NR2F2 | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | TiGER,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | OvarySoft tissue | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | OVSARC | |
| Reference showing the relevant tissue of NR2F2 | ||
| Description by TissGene annotations | Cancer gene | |
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 9343308 | GO:0030522 | intracellular receptor signaling pathway | 18798693 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 19210544 | GO:0045892 | negative regulation of transcription, DNA-templated | 19210544 | GO:0045893 | positive regulation of transcription, DNA-templated | 18798693 | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 9343308 | GO:0030522 | intracellular receptor signaling pathway | 18798693 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 19210544 | GO:0045892 | negative regulation of transcription, DNA-templated | 19210544 | GO:0045893 | positive regulation of transcription, DNA-templated | 18798693 |
| Top |
| TissGeneExp for NR2F2 |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| KICH | -0.287046202 | 1.571685798 | -1.858732 | 8.27E-12 | 8.14E-11 |
| Top |
| TissGene-miRNA for NR2F2 |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| UVM | hsa-miR-365a-3p | MIMAT0000710 | 0.019 | -0.26 | 80 |
| UVM | hsa-miR-365b-3p | MIMAT0022834 | 0.017 | -0.27 | 80 |
| Top |
| TissGeneMut for NR2F2 |
| TissGeneSNV for NR2F2 |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.S101G | KIRP | 1 |
| p.P234R | KIRP | 1 |
| p.E225* | LUAD | 1 |
| p.A257V | UCEC | 1 |
| p.R218K | CESC | 1 |
| p.R359K | STAD | 1 |
| p.R108W | COAD | 1 |
| p.I182L | UCEC | 1 |
| p.A317V | STAD | 1 |
| p.G208V | LIHC | 1 |
| p.Y353H | SKCM | 1 |
| p.R284W | ESCA | 1 |
| p.Y181H | STAD | 1 |
| p.Q150X | THYM | 1 |
| p.A258V | LGG | 1 |
| p.L337V | UCEC | 1 |
| p.G208A | GBM | 1 |
| p.R135S | LIHC | 1 |
| p.Y133H | KIRP | 1 |
| p.A412T | BLCA | 1 |
| p.E78D | LGG | 1 |
| p.K104N | HNSC | 1 |
| p.P234S | SKCM | 1 |
| p.Q414* | HNSC | 1 |
| p.Q342* | BLCA | 1 |
| p.G92C | HNSC | 1 |
| p.E300K | BLCA | 1 |
| p.A257G | LIHC | 1 |
| p.G255D | COAD | 1 |
| p.L220P | STAD | 1 |
| p.S106R | THYM | 1 |
| p.Q414* | CESC | 1 |
| p.R105G | PRAD | 1 |
| p.S329F | BLCA | 1 |
| p.G327D | UCEC | 1 |
| p.R293W | GBM | 1 |
| p.A258V | UCEC | 1 |
| p.Y220H | SKCM | 1 |
| p.A272P | HNSC | 1 |
| p.P101S | SKCM | 1 |
| p.R109M | KIRP | 1 |
| p.Q414* | LGG | 1 |
| p.A273S | BLCA | 1 |
| p.F103C | HNSC | 1 |
| p.R109W | OV | 1 |
| p.P171A | HNSC | 1 |
| p.G36R | SKCM | 1 |
| p.G169R | SKCM | 1 |
| p.P368T | CESC | 1 |
| p.P391H | KIRP | 1 |
| p.V373I | UCEC | 1 |
| p.R246H | LGG | 1 |
| p.Q73H | PAAD | 1 |
| p.R233C | COAD | 1 |
| p.A271G | HNSC | 1 |
| Top |
| TissGeneCNV for NR2F2 |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for NR2F2 |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Chimerdb3.0 | ChiTaRs | NA | AI214117 | NR2F2-MRTO4 | chr15:96880999 | chr1:19578335 | |
| Chimerdb3.0 | ChiTaRs | NA | CK725089 | NR2F2-NR2F2 | chr15:96875159 | chr15:96875180 | |
| Chimerdb3.0 | FusionScan | BRCA | TCGA-C8-A12P-01A | NR2F2-MSI2 | Out-of-Frame | chr15:96869581 | chr17:55607036 |
| TCGAfusionPortal | PRADA | BRCA | TCGA-C8-A12P-01A | NR2F2-MSI2 | Out-of-frame | Chr15:96869581 | Chr17:55607037 |
| Top |
| TissGeneNet for NR2F2 |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| BRCA (tumor) | BRCA (normal) |
| NR2F2, NR3C1, FAM46A, GATA2, HDAC1, MYOD1, NCOR2, EP300, APOB, HIPK3, APOA1, POU5F1, PHB2, BIK, BCL11A, HBG2, PIAS1, SETD7, NR2F6, TFAP4, HBE1 (tumor) | NR2F2, LCK, NR3C1, HNF4A, FAM46A, GATA2, HDAC1, MYOD1, EP300, APOB, HIPK3, POU5F1, PHB2, BIK, BCL11A, PIAS1, SETD7, TRIP4, NR2F6, TFAP4, CYP7A1 (normal) |
 |  |
| COAD (tumor) | COAD (normal) |
| NR2F2, LCK, NR3C1, HNF4A, GATA2, HDAC1, NCOR2, EP300, ACTA1, HIPK3, POU5F1, TRIM24, PHB2, BIK, BCL11A, PIAS1, SETD7, TRIP4, NR2F6, BCL11B, HBE1 (tumor) | NR2F2, LCK, NR3C1, FAM46A, GATA2, HDAC1, MYOD1, NCOR2, EP300, APOB, HIPK3, POU5F1, TRIM24, PHB2, BIK, BCL11A, PIAS1, SETD7, TRIP4, NR2F6, TFAP4 (normal) |
 |  |
| HNSC (tumor) | HNSC (normal) |
| NR2F2, SQSTM1, LCK, NR3C1, HNF4A, FAM46A, GATA2, HDAC1, NCOR2, APOB, POU5F1, PHB2, BCL11A, HBG2, SETD7, TRIP4, TFAP4, BCL11B, CYP7A1, CYP11B2, HBE1 (tumor) | NR2F2, SQSTM1, LCK, NR3C1, HNF4A, GATA2, HDAC1, MYOD1, NCOR2, EP300, APOB, ACTA1, HIPK3, TRIM24, BIK, PIAS1, SETD7, TRIP4, NR2F6, TFAP4, BCL11B (normal) |
 |  |
| KICH (tumor) | KICH (normal) |
| NR2F2, SQSTM1, NR3C1, FAM46A, GATA2, NCOR2, EP300, TRIM24, PHB2, BIK, BCL11A, HBG2, PIAS1, SETD7, TRIP4, NR2F6, TFAP4, BCL11B, F9, HBE1, APOA4 (tumor) | NR2F2, SQSTM1, LCK, NR3C1, HNF4A, FAM46A, GATA2, MYOD1, NCOR2, EP300, APOA1, POU5F1, TRIM24, PHB2, PIAS1, NR2F6, TFAP4, BCL11B, CYP7A1, APOC3, HBE1 (normal) |
 |  |
| KIRC (tumor) | KIRC (normal) |
| NR2F2, SQSTM1, GATA2, HDAC1, NCOR2, EP300, APOB, APOA1, TRIM24, PHB2, BIK, BCL11A, PIAS1, SETD7, NR2F6, TFAP4, BCL11B, CYP7A1, APOC3, HBE1, APOA4 (tumor) | NR2F2, SQSTM1, NR3C1, FAM46A, GATA2, HDAC1, EP300, ACTA1, HIPK3, TRIM24, PHB2, BCL11A, PIAS1, SETD7, NR2F6, TFAP4, BCL11B, CYP7A1, APOC3, HBE1, APOA4 (normal) |
 |  |
| KIRP (tumor) | KIRP (normal) |
| NR2F2, LCK, FAM46A, GATA2, HDAC1, MYOD1, NCOR2, HIPK3, APOA1, BIK, BCL11A, HBG2, PIAS1, SETD7, TRIP4, NR2F6, HBG1, TFAP4, BCL11B, APOC3, APOA4 (tumor) | NR2F2, SQSTM1, LCK, NR3C1, HNF4A, MYOD1, NCOR2, EP300, HIPK3, APOA1, POU5F1, TRIM24, PHB2, BIK, BCL11A, PIAS1, SETD7, NR2F6, BCL11B, APOC3, APOA4 (normal) |
 |  |
| LIHC (tumor) | LIHC (normal) |
| NR2F2, SQSTM1, LCK, NR3C1, HNF4A, FAM46A, HDAC1, NCOR2, EP300, APOB, HIPK3, TRIM24, PHB2, BIK, BCL11A, PIAS1, SETD7, NR2F6, BCL11B, CYP7A1, APOA4 (tumor) | NR2F2, SQSTM1, LCK, NR3C1, HNF4A, GATA2, NCOR2, EP300, APOB, HIPK3, APOA1, PHB2, BCL11A, PIAS1, SETD7, TRIP4, NR2F6, BCL11B, CYP7A1, F9, APOC3 (normal) |
 |  |
| LUAD (tumor) | LUAD (normal) |
| NR2F2, SQSTM1, LCK, NR3C1, HNF4A, FAM46A, GATA2, HDAC1, EP300, APOB, HIPK3, POU5F1, TRIM24, BIK, BCL11A, PIAS1, SETD7, NR2F6, TFAP4, BCL11B, APOA4 (tumor) | NR2F2, LCK, NR3C1, HNF4A, GATA2, NCOR2, EP300, APOB, ACTA1, HIPK3, POU5F1, TRIM24, PHB2, BIK, PIAS1, SETD7, TRIP4, NR2F6, TFAP4, BCL11B, CYP7A1 (normal) |
 |  |
| LUSC (tumor) | LUSC (normal) |
| NR2F2, SQSTM1, LCK, NR3C1, HNF4A, FAM46A, GATA2, HDAC1, EP300, APOB, HIPK3, POU5F1, TRIM24, BIK, BCL11A, PIAS1, SETD7, TRIP4, TFAP4, BCL11B, F9 (tumor) | NR2F2, SQSTM1, LCK, HNF4A, FAM46A, GATA2, MYOD1, NCOR2, EP300, APOB, ACTA1, HIPK3, POU5F1, PHB2, BIK, PIAS1, TRIP4, HBG1, TFAP4, BCL11B, CYP7A1 (normal) |
 |  |
| PRAD (tumor) | PRAD (normal) |
| NR2F2, LCK, NR3C1, HNF4A, FAM46A, HDAC1, MYOD1, APOB, ACTA1, HIPK3, APOA1, TRIM24, PHB2, BIK, BCL11A, PIAS1, TRIP4, BCL11B, CYP7A1, F9, HBE1 (tumor) | NR2F2, SQSTM1, NR3C1, FAM46A, HDAC1, NCOR2, EP300, APOB, ACTA1, HIPK3, APOA1, POU5F1, TRIM24, PHB2, BIK, BCL11A, PIAS1, SETD7, NR2F6, BCL11B, CYP7A1 (normal) |
 |  |
| STAD (tumor) | STAD (normal) |
| NR2F2, SQSTM1, NR3C1, FAM46A, GATA2, HDAC1, NCOR2, EP300, ACTA1, HIPK3, POU5F1, TRIM24, BIK, BCL11A, PIAS1, SETD7, TRIP4, NR2F6, TFAP4, BCL11B, HBE1 (tumor) | NR2F2, NR3C1, HNF4A, FAM46A, GATA2, HDAC1, NCOR2, EP300, APOB, ACTA1, HIPK3, POU5F1, TRIM24, PHB2, BIK, SETD7, TRIP4, NR2F6, TFAP4, APOC3, CYP11B2 (normal) |
 |  |
| THCA (tumor) | THCA (normal) |
| NR2F2, SQSTM1, LCK, NR3C1, HNF4A, GATA2, HDAC1, MYOD1, NCOR2, EP300, APOB, POU5F1, TRIM24, PHB2, BIK, HBG2, SETD7, TFAP4, BCL11B, APOC3, APOA4 (tumor) | NR2F2, SQSTM1, LCK, NR3C1, FAM46A, GATA2, HDAC1, EP300, APOB, ACTA1, HIPK3, APOA1, POU5F1, TRIM24, PHB2, BCL11A, TRIP4, NR2F6, BCL11B, CYP7A1, APOA4 (normal) |
 |  |
| Top |
| TissGeneProg for NR2F2 |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
 |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Top |
| TissGeneClin for NR2F2 |
| TissGeneDrug for NR2F2 |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for NR2F2 |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C0006142 | Malignant neoplasm of breast | 10 | BeFree |
| umls:C0678222 | Breast Carcinoma | 10 | BeFree |
| umls:C0026764 | Multiple Myeloma | 5 | BeFree |
| umls:C0027627 | Neoplasm Metastasis | 4 | BeFree |
| umls:C0235833 | Congenital diaphragmatic hernia | 4 | BeFree,MGD |
| umls:C0014175 | Endometriosis | 3 | BeFree,CTD_human |
| umls:C0596263 | Carcinogenesis | 3 | BeFree |
| umls:C0000768 | Congenital Abnormality | 2 | BeFree |
| umls:C0018798 | Congenital Heart Defects | 2 | BeFree |
| umls:C0030297 | Pancreatic Neoplasm | 2 | BeFree |
| umls:C0035869 | Rotavirus Infections | 2 | BeFree |
| umls:C0376358 | Malignant neoplasm of prostate | 2 | BeFree |
| umls:C0600139 | Prostate carcinoma | 2 | BeFree |
| umls:C1458155 | Mammary Neoplasms | 2 | BeFree |
| umls:C0003850 | Arteriosclerosis | 1 | BeFree |
| umls:C0003873 | Rheumatoid Arthritis | 1 | GAD |
| umls:C0004153 | Atherosclerosis | 1 | BeFree |
| umls:C0007102 | Malignant tumor of colon | 1 | BeFree |
| umls:C0009402 | Colorectal Carcinoma | 1 | BeFree |
| umls:C0009404 | Colorectal Neoplasms | 1 | LHGDN |
| umls:C0010346 | Crohn Disease | 1 | GAD |
| umls:C0011854 | Diabetes Mellitus, Insulin-Dependent | 1 | GAD |
| umls:C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | GAD |
| umls:C0019284 | Diaphragmatic Hernia | 1 | CTD_human |
| umls:C0019693 | HIV Infections | 1 | BeFree |
| umls:C0020538 | Hypertensive disease | 1 | GAD |
| umls:C0021051 | Immunologic Deficiency Syndromes | 1 | BeFree |
| umls:C0021361 | Female infertility | 1 | CTD_human |
| umls:C0023267 | Fibroid Tumor | 1 | BeFree |
| umls:C0023418 | leukemia | 1 | BeFree |
| umls:C0023903 | Liver neoplasms | 1 | BeFree |
| umls:C0026769 | Multiple Sclerosis | 1 | BeFree |
| umls:C0027708 | Nephroblastoma | 1 | BeFree |
| umls:C0029124 | Optic Atrophy | 1 | BeFree |
| umls:C0029925 | Ovarian Carcinoma | 1 | BeFree |
| umls:C0037769 | West Syndrome | 1 | BeFree |
| umls:C0042133 | Uterine Fibroids | 1 | BeFree |
| umls:C0085669 | Acute leukemia | 1 | BeFree |
| umls:C0178874 | Tumor Progression | 1 | BeFree |
| umls:C0220766 | Congenital hypoplasia of adrenal gland | 1 | BeFree |
| umls:C0235974 | Pancreatic carcinoma | 1 | BeFree |
| umls:C0242379 | Malignant neoplasm of lung | 1 | BeFree |
| umls:C0279628 | Adenocarcinoma Of Esophagus | 1 | BeFree |
| umls:C0281361 | Adenocarcinoma of pancreas | 1 | BeFree |
| umls:C0338106 | Adenocarcinoma of colon | 1 | BeFree |
| umls:C0342276 | Maturity onset diabetes mellitus in young | 1 | BeFree |
| umls:C0346647 | Malignant neoplasm of pancreas | 1 | BeFree |
| umls:C0684249 | Carcinoma of lung | 1 | BeFree |
| umls:C0686619 | Secondary malignant neoplasm of lymph node | 1 | BeFree |
| umls:C0699790 | Colon Carcinoma | 1 | BeFree |
| umls:C0752123 | Spinocerebellar Ataxia Type 5 | 1 | BeFree |
| umls:C1140680 | Malignant neoplasm of ovary | 1 | BeFree |
| umls:C1176475 | Ductal Carcinoma | 1 | BeFree |
| umls:C1319315 | Adenocarcinoma of large intestine | 1 | BeFree |
| umls:C1527249 | Colorectal Cancer | 1 | BeFree |
| umls:C1720816 | Endometrial Diseases | 1 | BeFree |
| umls:C1852093 | Maturity-Onset Diabetes of the Young, Type 1 | 1 | BeFree |
| umls:C1956346 | Coronary Artery Disease | 1 | GAD |
| umls:C2239176 | Liver carcinoma | 1 | BeFree |
| umls:C3714756 | Intellectual Disability | 1 | BeFree |
| umls:C4014310 | CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4 | 1 | UNIPROT |
| umls:C0221215 | Common atrioventricular canal | 0 | ORPHANET |
| umls:C0344735 | Partial atrioventricular canal | 0 | ORPHANET |
| umls:C0344787 | Complete atrioventricular septal defect | 0 | ORPHANET |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |